A game of monopoly

Reed Elsevier's proposed takeover of Harcourt has provoked an outcry from librarians and academics alike - but do they have the muscle to influence it?

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

LONDON. Scholarly publishing faces a stern test of its integrity, following one of the largest proposed acquisitions in recent years. On 27 October, Reed Elsevier reached an agreement to acquire Harcourt's scientific, technical and medical businesses as part of a more general acquisition of Harcourt General Inc for $4.5 billion in cash, plus the assumption of $1.2 billion in debt. Reed Elsevier then intends to sell on the Harcourt adult education divisions to Thompson Corporation for $2.1 billion.

Academics and other publishers can only stand by and watch as US authorities consider pleas from the opposition — mainly library research associations — for the acquisition to be disallowed on regulatory grounds. If the deal receives shareholder and regulatory approval, it will make Reed Elsevier the market leader in medical and science publishing.

In 1998, a proposed merger between Reed Elsevier and Wolters Kluwer provoked a worried reaction from US academic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • David Nicholson

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio